Listed

Beta Bionics, Inc.

BBNXNasdaqCIK 1674632HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$35.5m, Q3 FY2026
Operating income−$26.6m, Q3 FY2026
Net income−$24.4m, Q3 FY2026
Beta Bionics, Inc., income statement, quarterly
Line itemUnitperiod not labelled2024-03-31period not labelled2024-06-30period not labelled2024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Revenue$m12.9Revenue, period not labelled, three months to 2024-03-31$12.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-06, accession 0000950170-25-064504.Report this figure15.0Revenue, period not labelled, three months to 2024-06-30$15.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-07-29, accession 0000950170-25-099652.Report this figure16.7Revenue, period not labelled, three months to 2024-09-30$16.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-28, accession 0001193125-25-253538.Report this figure20.4Revenue, Q4 FY2024, three months to 2024-12-31$20.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001193125-26-067065. Derived: 12-month figure less the 9-month figure.Report this figure17.6Revenue, Q1 FY2025, three months to 2025-03-31$17.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-21, accession 0001193125-26-166843.Report this figure23.2Revenue, Q2 FY2025, three months to 2025-06-30$23.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0001193125-26-323777.Report this figure27.3Revenue, Q3 FY2025, three months to 2025-09-30$27.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure32.1Revenue, Q4 FY2025, three months to 2025-12-31$32.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001193125-26-067065. Derived: 12-month figure less the 9-month figure.Report this figure27.6Revenue, Q1 FY2026, three months to 2026-03-31$27.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-21, accession 0001193125-26-166843.Report this figure32.0Revenue, Q2 FY2026, three months to 2026-06-30$32.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0001193125-26-323777.Report this figure35.5Revenue, Q3 FY2026, three months to 2026-09-30$35.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure
Cost of revenue$m5.7Cost of revenue, period not labelled, three months to 2024-03-31$5.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-06, accession 0000950170-25-064504.Report this figure7.0Cost of revenue, period not labelled, three months to 2024-06-30$7.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-07-29, accession 0000950170-25-099652.Report this figure7.8Cost of revenue, period not labelled, three months to 2024-09-30$7.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-10-28, accession 0001193125-25-253538.Report this figure8.8Cost of revenue, Q4 FY2024, three months to 2024-12-31$8.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-24, accession 0001193125-26-067065. Derived: 12-month figure less the 9-month figure.Report this figure8.7Cost of revenue, Q1 FY2025, three months to 2025-03-31$8.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-04-21, accession 0001193125-26-166843.Report this figure10.7Cost of revenue, Q2 FY2025, three months to 2025-06-30$10.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-07-29, accession 0001193125-26-323777.Report this figure12.1Cost of revenue, Q3 FY2025, three months to 2025-09-30$12.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure13.2Cost of revenue, Q4 FY2025, three months to 2025-12-31$13.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-24, accession 0001193125-26-067065. Derived: 12-month figure less the 9-month figure.Report this figure11.2Cost of revenue, Q1 FY2026, three months to 2026-03-31$11.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-04-21, accession 0001193125-26-166843.Report this figure13.1Cost of revenue, Q2 FY2026, three months to 2026-06-30$13.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-07-29, accession 0001193125-26-323777.Report this figure15.2Cost of revenue, Q3 FY2026, three months to 2026-09-30$15.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure
Gross profit$m7.2Gross profit, period not labelled, three months to 2024-03-31$7.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-06, accession 0000950170-25-064504.Report this figure8.1Gross profit, period not labelled, three months to 2024-06-30$8.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-07-29, accession 0000950170-25-099652.Report this figure8.9Gross profit, period not labelled, three months to 2024-09-30$8.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-10-28, accession 0001193125-25-253538.Report this figure11.7Gross profit, Q4 FY2024, three months to 2024-12-31$11.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-24, accession 0001193125-26-067065. Derived: 12-month figure less the 9-month figure.Report this figure9.0Gross profit, Q1 FY2025, three months to 2025-03-31$9.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-21, accession 0001193125-26-166843.Report this figure12.5Gross profit, Q2 FY2025, three months to 2025-06-30$12.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-29, accession 0001193125-26-323777.Report this figure15.1Gross profit, Q3 FY2025, three months to 2025-09-30$15.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure18.9Gross profit, Q4 FY2025, three months to 2025-12-31$18.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-24, accession 0001193125-26-067065. Derived: 12-month figure less the 9-month figure.Report this figure16.4Gross profit, Q1 FY2026, three months to 2026-03-31$16.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-21, accession 0001193125-26-166843.Report this figure18.9Gross profit, Q2 FY2026, three months to 2026-06-30$18.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-29, accession 0001193125-26-323777.Report this figure20.3Gross profit, Q3 FY2026, three months to 2026-09-30$20.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure
Research and development$m5.5Research and development, period not labelled, three months to 2024-03-31$5.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-06, accession 0000950170-25-064504.Report this figure6.4Research and development, period not labelled, three months to 2024-06-30$6.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-07-29, accession 0000950170-25-099652.Report this figure5.1Research and development, period not labelled, three months to 2024-09-30$5.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-28, accession 0001193125-25-253538.Report this figure9.2Research and development, Q4 FY2024, three months to 2024-12-31$9.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-24, accession 0001193125-26-067065. Derived: 12-month figure less the 9-month figure.Report this figure7.6Research and development, Q1 FY2025, three months to 2025-03-31$7.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-21, accession 0001193125-26-166843.Report this figure8.9Research and development, Q2 FY2025, three months to 2025-06-30$8.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-29, accession 0001193125-26-323777.Report this figure8.2Research and development, Q3 FY2025, three months to 2025-09-30$8.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure10.1Research and development, Q4 FY2025, three months to 2025-12-31$10.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-24, accession 0001193125-26-067065. Derived: 12-month figure less the 9-month figure.Report this figure10.4Research and development, Q1 FY2026, three months to 2026-03-31$10.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-21, accession 0001193125-26-166843.Report this figure10.2Research and development, Q2 FY2026, three months to 2026-06-30$10.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-29, accession 0001193125-26-323777.Report this figure12.0Research and development, Q3 FY2026, three months to 2026-09-30$12.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure
Operating income$m(9.5)Operating income, period not labelled, three months to 2024-03-31−$9.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-06, accession 0000950170-25-064504.Report this figure(11.8)Operating income, period not labelled, three months to 2024-06-30−$11.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-07-29, accession 0000950170-25-099652.Report this figure(11.0)Operating income, period not labelled, three months to 2024-09-30−$11.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-28, accession 0001193125-25-253538.Report this figure(13.0)Operating income, Q4 FY2024, three months to 2024-12-31−$13.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-24, accession 0001193125-26-067065. Derived: 12-month figure less the 9-month figure.Report this figure(18.6)Operating income, Q1 FY2025, three months to 2025-03-31−$18.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-21, accession 0001193125-26-166843.Report this figure(19.9)Operating income, Q2 FY2025, three months to 2025-06-30−$19.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-29, accession 0001193125-26-323777.Report this figure(17.0)Operating income, Q3 FY2025, three months to 2025-09-30−$17.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure(16.1)Operating income, Q4 FY2025, three months to 2025-12-31−$16.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-24, accession 0001193125-26-067065. Derived: 12-month figure less the 9-month figure.Report this figure(24.3)Operating income, Q1 FY2026, three months to 2026-03-31−$24.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-21, accession 0001193125-26-166843.Report this figure(25.6)Operating income, Q2 FY2026, three months to 2026-06-30−$25.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-29, accession 0001193125-26-323777.Report this figure(26.6)Operating income, Q3 FY2026, three months to 2026-09-30−$26.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure
Net income$m(12.4)Net income, period not labelled, three months to 2024-03-31−$12.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-06, accession 0000950170-25-064504.Report this figure(14.5)Net income, period not labelled, three months to 2024-06-30−$14.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-07-29, accession 0000950170-25-099652.Report this figure(9.7)Net income, period not labelled, three months to 2024-09-30−$9.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-28, accession 0001193125-25-253538.Report this figure(18.1)Net income, Q4 FY2024, three months to 2024-12-31−$18.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001193125-26-067065. Derived: 12-month figure less the 9-month figure.Report this figure(28.7)Net income, Q1 FY2025, three months to 2025-03-31−$28.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-21, accession 0001193125-26-166843.Report this figure(16.9)Net income, Q2 FY2025, three months to 2025-06-30−$16.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-29, accession 0001193125-26-323777.Report this figure(14.2)Net income, Q3 FY2025, three months to 2025-09-30−$14.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure(13.5)Net income, Q4 FY2025, three months to 2025-12-31−$13.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001193125-26-067065. Derived: 12-month figure less the 9-month figure.Report this figure(21.9)Net income, Q1 FY2026, three months to 2026-03-31−$21.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-21, accession 0001193125-26-166843.Report this figure(23.4)Net income, Q2 FY2026, three months to 2026-06-30−$23.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-29, accession 0001193125-26-323777.Report this figure(24.4)Net income, Q3 FY2026, three months to 2026-09-30−$24.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure
Diluted EPS$ per share(2.07)Diluted EPS, period not labelled, three months to 2024-03-31−$2.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-06, accession 0000950170-25-064504.Report this figure(2.37)Diluted EPS, period not labelled, three months to 2024-06-30−$2.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-07-29, accession 0000950170-25-099652.Report this figure(1.46)Diluted EPS, period not labelled, three months to 2024-09-30−$1.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-28, accession 0001193125-25-253538.Report this figurenot reported(0.93)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.93 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-21, accession 0001193125-26-166843.Report this figure(0.39)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-29, accession 0001193125-26-323777.Report this figure(0.33)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figurenot reported(0.49)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.49 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-21, accession 0001193125-26-166843.Report this figure(0.53)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.53 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-29, accession 0001193125-26-323777.Report this figure(0.52)Diluted EPS, Q3 FY2026, three months to 2026-09-30−$0.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure
Basic EPS$ per share(2.07)Basic EPS, period not labelled, three months to 2024-03-31−$2.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-06, accession 0000950170-25-064504.Report this figure(2.37)Basic EPS, period not labelled, three months to 2024-06-30−$2.37 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-07-29, accession 0000950170-25-099652.Report this figure(1.46)Basic EPS, period not labelled, three months to 2024-09-30−$1.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-28, accession 0001193125-25-253538.Report this figurenot reported(0.93)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.93 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-21, accession 0001193125-26-166843.Report this figure(0.39)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.39 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-29, accession 0001193125-26-323777.Report this figure(0.33)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figurenot reported(0.49)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.49 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-21, accession 0001193125-26-166843.Report this figure(0.53)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.53 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-29, accession 0001193125-26-323777.Report this figure(0.52)Basic EPS, Q3 FY2026, three months to 2026-09-30−$0.52 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure

Balance sheet

Cash and equivalents$81.6m, Q3 FY2026
Shareholders' equity$401.4m, Q3 FY2026
Beta Bionics, Inc., balance sheet, quarterly
Line itemUnitperiod not labelled2023-12-31period not labelled2024-03-31period not labelled2024-06-30period not labelled2024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Cash and equivalents$m26.6Cash and equivalents, period not labelled, at 2023-12-31$26.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K/A filed 2025-03-28, accession 0000950170-25-046762.Report this figure22.1Cash and equivalents, period not labelled, at 2024-03-31$22.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-06, accession 0000950170-25-064504.Report this figure13.0Cash and equivalents, period not labelled, at 2024-06-30$13.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-07-29, accession 0000950170-25-099652.Report this figure17.5Cash and equivalents, period not labelled, at 2024-09-30$17.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-28, accession 0001193125-25-253538.Report this figure30.4Cash and equivalents, FY2024, at 2024-12-31$30.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-24, accession 0001193125-26-067065.Report this figure42.5Cash and equivalents, Q1 FY2025, at 2025-03-31$42.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-21, accession 0001193125-26-166843.Report this figure35.1Cash and equivalents, Q2 FY2025, at 2025-06-30$35.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-29, accession 0001193125-26-323777.Report this figure38.5Cash and equivalents, Q3 FY2025, at 2025-09-30$38.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure31.6Cash and equivalents, FY2025, at 2025-12-31$31.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure30.2Cash and equivalents, Q1 FY2026, at 2026-03-31$30.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-21, accession 0001193125-26-166843.Report this figure44.3Cash and equivalents, Q2 FY2026, at 2026-06-30$44.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-29, accession 0001193125-26-323777.Report this figure81.6Cash and equivalents, Q3 FY2026, at 2026-09-30$81.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure
Current assets$m104Current assets, period not labelled, at 2023-12-31$103.6m. XBRL concept us-gaap:AssetsCurrent. 10-K/A filed 2025-03-28, accession 0000950170-25-046762.Report this figurenot reportednot reportednot reported133Current assets, FY2024, at 2024-12-31$132.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-24, accession 0001193125-26-067065.Report this figure262Current assets, Q1 FY2025, at 2025-03-31$261.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-06, accession 0000950170-25-064504.Report this figure286Current assets, Q2 FY2025, at 2025-06-30$286.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-07-29, accession 0000950170-25-099652.Report this figure270Current assets, Q3 FY2025, at 2025-09-30$270.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-10-28, accession 0001193125-25-253538.Report this figure268Current assets, FY2025, at 2025-12-31$267.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure248Current assets, Q1 FY2026, at 2026-03-31$248.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-04-21, accession 0001193125-26-166843.Report this figure231Current assets, Q2 FY2026, at 2026-06-30$231.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-29, accession 0001193125-26-323777.Report this figure293Current assets, Q3 FY2026, at 2026-09-30$292.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure
Total assets$m110Total assets, period not labelled, at 2023-12-31$110.0m. XBRL concept us-gaap:Assets. 10-K/A filed 2025-03-28, accession 0000950170-25-046762.Report this figurenot reportednot reportednot reported150Total assets, FY2024, at 2024-12-31$149.6m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-24, accession 0001193125-26-067065.Report this figure338Total assets, Q1 FY2025, at 2025-03-31$338.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-06, accession 0000950170-25-064504.Report this figure330Total assets, Q2 FY2025, at 2025-06-30$330.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-07-29, accession 0000950170-25-099652.Report this figure330Total assets, Q3 FY2025, at 2025-09-30$330.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-10-28, accession 0001193125-25-253538.Report this figure329Total assets, FY2025, at 2025-12-31$328.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure304Total assets, Q1 FY2026, at 2026-03-31$304.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-04-21, accession 0001193125-26-166843.Report this figure292Total assets, Q2 FY2026, at 2026-06-30$292.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-29, accession 0001193125-26-323777.Report this figure444Total assets, Q3 FY2026, at 2026-09-30$443.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure
Current liabilities$m10.6Current liabilities, period not labelled, at 2023-12-31$10.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K/A filed 2025-03-28, accession 0000950170-25-046762.Report this figurenot reportednot reportednot reported21.1Current liabilities, FY2024, at 2024-12-31$21.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-24, accession 0001193125-26-067065.Report this figure16.5Current liabilities, Q1 FY2025, at 2025-03-31$16.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-06, accession 0000950170-25-064504.Report this figure19.5Current liabilities, Q2 FY2025, at 2025-06-30$19.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-07-29, accession 0000950170-25-099652.Report this figure25.4Current liabilities, Q3 FY2025, at 2025-09-30$25.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-10-28, accession 0001193125-25-253538.Report this figure30.9Current liabilities, FY2025, at 2025-12-31$30.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure23.2Current liabilities, Q1 FY2026, at 2026-03-31$23.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-04-21, accession 0001193125-26-166843.Report this figure26.0Current liabilities, Q2 FY2026, at 2026-06-30$26.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-29, accession 0001193125-26-323777.Report this figure32.8Current liabilities, Q3 FY2026, at 2026-09-30$32.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure
Total liabilities$m51.4Total liabilities, period not labelled, at 2023-12-31$51.4m. XBRL concept us-gaap:Liabilities. 10-K/A filed 2025-03-28, accession 0000950170-25-046762.Report this figurenot reportednot reportednot reported73.6Total liabilities, FY2024, at 2024-12-31$73.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-24, accession 0001193125-26-067065.Report this figure24.3Total liabilities, Q1 FY2025, at 2025-03-31$24.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-06, accession 0000950170-25-064504.Report this figure28.3Total liabilities, Q2 FY2025, at 2025-06-30$28.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-07-29, accession 0000950170-25-099652.Report this figure35.3Total liabilities, Q3 FY2025, at 2025-09-30$35.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-10-28, accession 0001193125-25-253538.Report this figure41.1Total liabilities, FY2025, at 2025-12-31$41.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure33.2Total liabilities, Q1 FY2026, at 2026-03-31$33.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-04-21, accession 0001193125-26-166843.Report this figure36.0Total liabilities, Q2 FY2026, at 2026-06-30$36.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-29, accession 0001193125-26-323777.Report this figure42.4Total liabilities, Q3 FY2026, at 2026-09-30$42.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure
Shareholders' equity$m(203)Shareholders' equity, period not labelled, at 2023-12-31−$203.1m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-24, accession 0001193125-26-067065.Report this figure(214)Shareholders' equity, period not labelled, at 2024-03-31−$214.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-07-29, accession 0000950170-25-099652.Report this figure(221)Shareholders' equity, period not labelled, at 2024-06-30−$221.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-28, accession 0001193125-25-253538.Report this figure(229)Shareholders' equity, period not labelled, at 2024-09-30−$228.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-28, accession 0001193125-25-253538.Report this figure(245)Shareholders' equity, FY2024, at 2024-12-31−$245.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure314Shareholders' equity, Q1 FY2025, at 2025-03-31$313.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-29, accession 0001193125-26-323777.Report this figure302Shareholders' equity, Q2 FY2025, at 2025-06-30$301.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure295Shareholders' equity, Q3 FY2025, at 2025-09-30$294.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure288Shareholders' equity, FY2025, at 2025-12-31$287.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure271Shareholders' equity, Q1 FY2026, at 2026-03-31$271.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-29, accession 0001193125-26-323777.Report this figure256Shareholders' equity, Q2 FY2026, at 2026-06-30$256.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure401Shareholders' equity, Q3 FY2026, at 2026-09-30$401.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure

Cash flow

Operating cash flow−$12.3m, Q3 FY2026
Capital expenditure$2.3m, Q3 FY2026
Beta Bionics, Inc., cash flow, quarterly
Line itemUnitperiod not labelled2024-03-31period not labelled2024-06-30period not labelled2024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Operating cash flow$m(12.1)Operating cash flow, period not labelled, three months to 2024-03-31−$12.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-06, accession 0000950170-25-064504.Report this figure(12.2)Operating cash flow, period not labelled, three months to 2024-06-30−$12.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-07-29, accession 0000950170-25-099652. Derived: 6-month figure less the 3-month figure.Report this figure(9.6)Operating cash flow, period not labelled, three months to 2024-09-30−$9.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-28, accession 0001193125-25-253538. Derived: 9-month figure less the 6-month figure.Report this figure(14.3)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$14.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001193125-26-067065. Derived: 12-month figure less the 9-month figure.Report this figure(20.0)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$20.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-21, accession 0001193125-26-166843.Report this figure(13.6)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$13.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-29, accession 0001193125-26-323777. Derived: 6-month figure less the 3-month figure.Report this figure(8.7)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$8.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-27, accession 0001674632-26-000003. Derived: 9-month figure less the 6-month figure.Report this figure(8.6)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$8.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001193125-26-067065. Derived: 12-month figure less the 9-month figure.Report this figure(23.8)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$23.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-21, accession 0001193125-26-166843.Report this figure(14.6)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$14.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-29, accession 0001193125-26-323777. Derived: 6-month figure less the 3-month figure.Report this figure(12.3)Operating cash flow, Q3 FY2026, three months to 2026-09-30−$12.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-27, accession 0001674632-26-000003. Derived: 9-month figure less the 6-month figure.Report this figure
Capital expenditure$m0.4Capital expenditure, period not labelled, three months to 2024-03-31$406.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-06, accession 0000950170-25-064504.Report this figure0.5Capital expenditure, period not labelled, three months to 2024-06-30$507.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-07-29, accession 0000950170-25-099652. Derived: 6-month figure less the 3-month figure.Report this figure1.9Capital expenditure, period not labelled, three months to 2024-09-30$1.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-28, accession 0001193125-25-253538. Derived: 9-month figure less the 6-month figure.Report this figure0.6Capital expenditure, Q4 FY2024, three months to 2024-12-31$561.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001193125-26-067065. Derived: 12-month figure less the 9-month figure.Report this figure0.3Capital expenditure, Q1 FY2025, three months to 2025-03-31$333.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-21, accession 0001193125-26-166843.Report this figure1.8Capital expenditure, Q2 FY2025, three months to 2025-06-30$1.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-29, accession 0001193125-26-323777. Derived: 6-month figure less the 3-month figure.Report this figure1.3Capital expenditure, Q3 FY2025, three months to 2025-09-30$1.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-27, accession 0001674632-26-000003. Derived: 9-month figure less the 6-month figure.Report this figure1.9Capital expenditure, Q4 FY2025, three months to 2025-12-31$1.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001193125-26-067065. Derived: 12-month figure less the 9-month figure.Report this figure1.4Capital expenditure, Q1 FY2026, three months to 2026-03-31$1.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-21, accession 0001193125-26-166843.Report this figure1.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$1.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-29, accession 0001193125-26-323777. Derived: 6-month figure less the 3-month figure.Report this figure2.3Capital expenditure, Q3 FY2026, three months to 2026-09-30$2.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-27, accession 0001674632-26-000003. Derived: 9-month figure less the 6-month figure.Report this figure

Shares

Diluted shares (weighted)46.54m, Q3 FY2026
Beta Bionics, Inc., shares, quarterly
Line itemUnitperiod not labelled2024-03-31period not labelled2024-06-30period not labelled2024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Diluted shares (weighted)m shares6.0Diluted shares (weighted), period not labelled, three months to 2024-03-316,021,882 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-06, accession 0000950170-25-064504.Report this figure6.1Diluted shares (weighted), period not labelled, three months to 2024-06-306,105,813 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-07-29, accession 0000950170-25-099652.Report this figure6.7Diluted shares (weighted), period not labelled, three months to 2024-09-306,660,493 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-28, accession 0001193125-25-253538.Report this figure30.7Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3130,714,769 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-21, accession 0001193125-26-166843.Report this figure43.4Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3043,390,652 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-29, accession 0001193125-26-323777.Report this figure43.6Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3043,634,006 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure44.4Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3144,436,274 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-21, accession 0001193125-26-166843.Report this figure44.5Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3044,545,293 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-29, accession 0001193125-26-323777.Report this figure46.5Diluted shares (weighted), Q3 FY2026, three months to 2026-09-3046,541,997 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure

Shares outstanding: 54.37mShares outstanding, period not labelled, at 2026-10-2654,367,067 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-10-27, accession 0001674632-26-000003.Report this figure at Oct 26, 2026, from the cover of the 10-Q filed Oct 27, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 27, 2026, 18:51 ET. Listed shows no prices and gives no investment advice.